These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28002131)

  • 41. Transitions in Pediatric Gastroenterology: Results of a National Provider Survey.
    Bensen R; McKenzie RB; Fernandes SM; Fishman LN
    J Pediatr Gastroenterol Nutr; 2016 Nov; 63(5):488-493. PubMed ID: 27027904
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of Inflammatory Bowel Disease during Pregnancy and Breastfeeding Varies Widely: A Need for Further Education.
    Huang VW; Chang HJ; Kroeker KI; Goodman KJ; Hegadoren KM; Dieleman LA; Fedorak RN
    Can J Gastroenterol Hepatol; 2016; 2016():6193275. PubMed ID: 27725926
    [No Abstract]   [Full Text] [Related]  

  • 43. From intravenous to subcutaneous infliximab in patients with inflammatory bowel disease: a pandemic-driven initiative.
    Verma AM; Patel A; Subramanian S; Smith PJ
    Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):88-89. PubMed ID: 33444534
    [No Abstract]   [Full Text] [Related]  

  • 44. Infliximab administered with shortened infusion times in a specialized IBD infusion unit: a prospective cohort study.
    Van Assche G; Vermeire S; Noman M; Amant C; Weyts E; Vleminckx A; Vermeyen MJ; Rutgeerts P
    J Crohns Colitis; 2010 Sep; 4(3):329-33. PubMed ID: 21122522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Variation in inflammatory bowel disease care among saudi pediatric gastroenterologists.
    Al-Sarkhy AA
    Saudi J Gastroenterol; 2017; 23(1):45-51. PubMed ID: 28139500
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Knowledge and predictors of dysplasia surveillance performance in inflammatory bowel diseases in Australia.
    Leong RW; Perry J; Campbell B; Koo J; Turner IB; Corte C; Fok IK
    Gastrointest Endosc; 2015 Oct; 82(4):708-714.e4. PubMed ID: 26007222
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association Between Infliximab Trough Levels and the Occurrence of Paradoxical Manifestations in Patients with Inflammatory Bowel Disease: a Case-Control Study.
    Coutzac C; Chapuis J; Poullenot F; Chabrun E; Capdepont M; Blanco P; Laharie D
    J Crohns Colitis; 2015 Nov; 9(11):982-7. PubMed ID: 26351388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Skin reactions during anti-TNFα therapy for pediatric inflammatory bowel disease: a 2-year prospective study.
    Mälkönen T; Wikström A; Heiskanen K; Merras-Salmio L; Mustonen H; Sipponen T; Kolho KL
    Inflamm Bowel Dis; 2014 Aug; 20(8):1309-15. PubMed ID: 24918318
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Infliximab in inflammatory bowel diseases--conference summary and suggested guidelines].
    Dotan I; Chowers Y; Rachmilewitz D; Chermesh I; Lavy A; Israeli E; Karban A; Schwaber MJ; Odes S; Eliakim R
    Harefuah; 2006 Nov; 145(11):844-9, 860. PubMed ID: 17183961
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A national survey on the patterns of treatment of inflammatory bowel disease in Canada.
    Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
    BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current Practice of Pharmacological Thromboprophylaxis for Prevention of Venous Thromboembolism in Hospitalized Children: A Survey of Pediatric Hemostasis and Thrombosis Experts in North America.
    Badawy SM; Rychlik K; Sharathkumar AA
    J Pediatr Hematol Oncol; 2016 May; 38(4):301-7. PubMed ID: 26925711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States.
    Tinsley A; Naymagon S; Trindade AJ; Sachar DB; Sands BE; Ullman TA
    J Clin Gastroenterol; 2013 Jan; 47(1):e1-6. PubMed ID: 22476043
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of COVID-19 outbreak on clinical practice and training of young gastroenterologists: A European survey.
    Marasco G; Nardone OM; Maida M; Boskoski I; Pastorelli L; Scaldaferri F;
    Dig Liver Dis; 2020 Dec; 52(12):1396-1402. PubMed ID: 32507619
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Survey of Immunization Practices in Patients With Inflammatory Bowel Disease Among Pediatric Gastroenterologists.
    Lester R; Lu Y; Tung J
    J Pediatr Gastroenterol Nutr; 2015 Jul; 61(1):47-51. PubMed ID: 25611033
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinicians' adherence to international guidelines in the clinical care of adults with inflammatory bowel disease.
    Jackson BD; Con D; Liew D; De Cruz P
    Scand J Gastroenterol; 2017 May; 52(5):536-542. PubMed ID: 28128675
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunomodulatory therapy for pediatric inflammatory bowel disease: changing patterns of use, 1990-2000.
    Markowitz J; Grancher K; Kohn N; Daum F
    Am J Gastroenterol; 2002 Apr; 97(4):928-32. PubMed ID: 12003428
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gastroenterologists' Views of Shared Decision Making for Patients with Inflammatory Bowel Disease.
    Siegel CA; Lofland JH; Naim A; Gollins J; Walls DM; Rudder LE; Reynolds C
    Dig Dis Sci; 2015 Sep; 60(9):2636-45. PubMed ID: 25939543
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Short article: Remicade infusions at home: an alternative setting of infliximab therapy for patients with Crohn's disease.
    Kuin S; Stolte SB; van den Brink GR; Ponsioen CY; Fockens P; D'Haens GR; Löwenberg M
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):222-5. PubMed ID: 26566062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence and drug treatment practices of inflammatory bowel diseases in Poland in the years 2012-2014: an analysis of nationwide databases.
    Holko P; Kawalec P; Stawowczyk E
    Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):456-464. PubMed ID: 29256907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.